Abstract
The microbiome, especially in early life, may play a role in asthma development and its severity. Early microbial interactions with the immune system are crucial for health, with exposure to bacteria like Streptococcus, Haemophilus and Moraxella linked to asthma in later childhood. C-sections, antibiotics and formula feeding affect microbiome development, increasing asthma risk. In adults with asthma, bacteria like Haemophilus influenzae and Moraxella catarrhalis are more prevalent. Commensal bacteria, such as Rothia mucilaginosa, can influence inflammation through mechanisms like NF-κB signalling. The lung–gut axis also plays a role in asthma development, with short-chain fatty acids from the gut potentially modulating immune responses. Emerging research suggests dietary interventions could aid asthma management. Multi-omics is being used to identify asthma endotypes, which may lead to precision medicines and new treatments. However, further research is needed to validate these findings and better understand asthma mechanisms.
| Original language | English |
|---|---|
| Pages (from-to) | 85-101 |
| Number of pages | 17 |
| Journal | ERS Monograph |
| Volume | 2025 |
| Issue number | 108 |
| DOIs | |
| Publication status | E-pub ahead of print - 1 Jun 2025 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine